S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
OTCMKTS:SSMXY

Sysmex - SSMXY Price Target & Analyst Ratings

$30.76
+0.29 (+0.95%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$30.67
$30.97
50-Day Range
$28.33
$35.83
52-Week Range
$27.54
$69.41
Volume
76,742 shs
Average Volume
57,921 shs
Market Capitalization
$12.90 billion
P/E Ratio
32.72
Dividend Yield
1.38%
Price Target
N/A

Sysmex Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 2 Analyst Ratings

Consensus Analyst Price Target

N/A

TypeCurrent
8/10/21 to 8/10/22
1 Month Ago
7/11/21 to 7/11/22
3 Months Ago
5/12/21 to 5/12/22
1 Year Ago
8/10/20 to 8/10/21
Consensus Rating
Moderate Buy
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
1 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Predicted UpsideN/AN/AN/AN/A
Get Sysmex Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SSMXY and its competitors with MarketBeat's FREE daily newsletter.


SSMXY Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SSMXY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Sysmex Stock vs. The Competition

TypeSysmexMedical CompaniesS&P 500
Consensus Rating Score
2.50
2.71
2.50
Consensus RatingModerate BuyBuyHold
Predicted Upside751.22% Upside18.99% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
81
56.25%
Underperform Votes
63
43.75%
Avg. Outperform Votes
167
66.80%
Avg. Underperform Votes
83
33.20%
Avg. Outperform Votes
840
68.68%
Avg. Underperform Votes
383
31.32%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/30/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy
11/26/2021Daiwa Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral
7/29/2021Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
6/28/2021Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Outperform
11/25/2020Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Neutral
11/26/2019Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
(Data available from 8/10/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












SSMXY Price Target - Frequently Asked Questions

What is Sysmex's consensus rating?

According to the issued ratings of 2 analysts in the last year, the consensus rating for Sysmex stock is Moderate Buy based on the current 1 hold rating and 1 buy rating for SSMXYthe . Learn more on SSMXY's analyst rating history.

Do Wall Street analysts like Sysmex more than its competitors?

Analysts like Sysmex less than other Medical companies. The consensus rating for Sysmex is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how SSMXY compares to other companies.

Do MarketBeat users like Sysmex more than its competitors?

MarketBeat users like Sysmex less than other Medical companies. 56.25% of MarketBeat users gave Sysmex an outperform vote while medical companies recieve an average of 66.80% outperform votes by MarketBeat users.

Is Sysmex being upgraded by Wall Street analysts?

Over the previous 90 days, Sysmex's stock had 1 upgrade by analysts.

What analysts cover Sysmex?

Sysmex has been rated by Citigroup in the past 90 days.


Stock Ratings Reports and Tools

This page (OTCMKTS:SSMXY) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.